|Management and Treatment of HCV Infection: Entering a New Era in 2011|
|Phyllis Tien, MD, Associate Professor of Medicine, UCSF, Staff Physician, SFVAMC|
|Dr. Phyllis Tien reviews recent studies of hepatitis C (HCV) management and treatment. She provides an overview of HCV therapy, highlighting its 2 primary goals of viral eradication and prevention of disease progression. She also describes the evolving range of agents available for treatment, including new direct-acting antiviral agents approved by the FDA.
| Presenter: Phyllis Tien, MD|
Dr. Tien is an Associate Professor in Medicine/Infectious Diseases at UCSF.
She studies metabolic consequences of HCV and HIV infection, particularly insulin resistance, lipodystrophy, and hepatic steatosis in men and women.
The activity consists of a slideshow accompanied by audio that can be viewed or browsed by all users. Following the slideshow presentation, users may complete a brief posttest to test their knowledge.